Collecting blood markers in pancreatic cancer patients
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study collects samples of substances in your blood to learn more about pancreatic cancer. It may help researchers find better ways to track the disease or understand which patients may benefit from future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been told you have pancreatic adenocarcinoma (or doctors strongly suspect it)
- You receive care at the University of Pennsylvania
- You can understand the study and sign an informed consent form
- You are 18 years old or older
- You don’t have major health, mental health, or social issues that would make it hard to follow the study or safely participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well a new blood-based test may help find pancreatic cancer earlier. You may join if you’re an adult who fits a specific risk group and can safely provide a blood sample.
This trial studies a blood test that looks for tiny traces of cancer-related DNA (called ctDNA) in people with pancreatic cancer that can be removed with surgery. The goal is to see whether this test can better predict how the cancer behaves and guide treatment decisions around surgery.
This study asks people receiving care at the University of Pennsylvania Hospital to provide samples that can help researchers study tumor material. If you have pancreatic disease—or you’re getting care for something else (like a routine colonoscopy)—your samples may be used to compare findings and improve future research.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This study tests a new blood test that uses epigenetics (chemical markers on DNA) to help diagnose pancreatic cancer. Researchers want to see if this test can accurately identify pancreatic cancer in people who have had it or are at high risk for developing it.
This study looks at “biomarkers” (test signals in tissue or blood) in people with pancreatic cancer. It may help researchers understand the disease better and find ways to predict or track it.
Hear when a new Pancreas Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.